Please Wait...

FSH // Follico-Stimulating Hormone

Biomarker Therapeutic Areas: 
Biomarker Matrices: 

Follicle-Stimulating Hormone is one of the four glycoprotein hormones. Proteins of this family share a common α subunit and have a specific β subunit. They present structural features of the superfamily of cysteine knot protein (this superfamily contain the TGFβ family, bone morphogenetic proteins, …) (Fan and Hendrickson, 2005; Grossmann et al., 1997; Vitt et al., 2001). FSH is secreted by the pituitary gland and binds its receptor expressed on granulosa cells from ovarian follicles and Sertoli cells of the testis, where activation induce cytodifferentiation, estrogen production and induction of LH receptor. FSH, in association with LH is a central hormone in the regulation of reproduction (Ryan et al., 1988). Injections of recombinant (and urinary) FSH are used in reproductive medicine for ovarian stimulation (van Wely et al., 2011).

Bioclinica Lab employs an automated chemiluminescent assay designed for the measurement of FSH in serum.

ADDITIONAL RESOURCES

Biomarker Menu

Download MENU

Molecular Marker Laboratory Services

Download Brochure

Alzheimer's Disease Biomarker Lab Expertise

Download Info Sheet

Leader in Clinical Trial
Management Solutions

Successful clinical trials require the ability to see key details and uncover hidden insights. Bioclinica utilizes science and technology to bring clarity to clinical trials, helping companies to develop new life-improving therapies more efficiently and safely.

We're hiring recent tech grads in #RTP for #pharma sector! Our innov. clinical financial solution gives our client… https://t.co/GHgOfszO0T
bioclinica (3 hours ago)
Great to be @DrugInfoAssn DIA China! Ask us @bioclinica how sponsors & CROs can optimize electronic data capture… https://t.co/TtE4AiLnqY
bioclinica (9 hours ago)
RT @bioclinica: Kinks in the clinical supply chain? Check out how one of our clients is using clinical supply optimization technology for m…
bioclinica (9 hours ago)
RT @bioclinica: Welcoming everyone to KOP for #OCTEast Coast!!
bioclinica (9 hours ago)
Welcoming everyone to KOP for #OCTEast Coast!!
bioclinica (Yesterday)
Case processing is an important aspect of post-marketing drug safety surveillance. Here's a case study showing how… https://t.co/UMYp92Puvc
bioclinica (2 days ago)

Latest Blogs:

Latin America: Benefit from the Right Partner
Removing Risk from Clinical Trial Management System (CTMS) Implementations
Collaboration Between Clinical Operations and the Logistics and Supply Chain Teams is Key to Trial Success
The Value of Protocol Review
CTMS and RBM: Hot Topics at OCT Nordics in Copenhagen